SBC Medical Group Establishes "SBC AI Longevity Innovation Inc." to Drive AI and Longevity Initiatives
Launches its first product, "SBC AI Assistant," at Shonan Beauty Clinic in early August.
SBC Medical Group Holdings Incorporated (Headquarters: California, USA; CEO: Yoshiyuki Aikawa; hereinafter "the Company"), a Medical Services Organization (MSO) providing management support to medical institutions in various clinical fields both in Japan and overseas, established a new subsidiary, "SBC AI Longevity Innovation Inc.," on July 1, 2026. The new entity is responsible for planning and developing products and services aimed at creating new value in the fields of AI and longevity.
The company’s first product is the "SBC AI Assistant," designed to handle customer consultations on the official Shonan Beauty Clinic website. Operating as an AI chatbot, it launched in early August 2026 to guide users through personalized inquiries, recommend optimal procedures and information, and provide a seamless navigation path to booking via MySBC or the call center.
Addressing Beginners' Uncertainty: "I Don't Know What to Choose"
While the official Shonan Beauty Clinic website provides comprehensive information—including cosmetic surgery, cosmetic dermatology, medical hair removal, pricing, campaigns, and clinic locations—first-time visitors often face information overload. This made it difficult to determine which treatment best suited their concerns, resulting in some users leaving without booking.
The SBC AI Assistant resolves this by holding interactive dialogues to organize customers' latent concerns and preferences, directing them straight to relevant treatments and information. By streamlining the booking path through the "MySBC" member portal and the call center, it lowers the barrier to consultation and delivers a smoother customer experience.
Key Features
Rather than presenting static information, this interactive AI chatbot helps clarify user interests and concerns through conversation. Primary features include:
Hearing customer concerns and preferences to automatically propose optimal treatment options.
Providing immediate answers to pre-visit inquiries regarding prices, campaigns, clinic access, and more.
Seamlessly guiding users toward booking via "MySBC" or the call center.
These functions enable a user-friendly environment where customers can seek advice anytime and anywhere, enhancing the overall Customer Experience (CX). Please note that this service provides general information and does not constitute medical diagnosis or individual treatment evaluation. Final diagnoses and suitability for procedures are determined solely through physician consultations.
The Company views AI not merely as a tool for operational efficiency, but as a foundation to fundamentally elevate customer experience and medical service quality. Moving forward, the Company will continue integrating technology with medical insights to build an environment where customers can select optimal healthcare services with confidence.
SBC AI Longevity Innovation Inc.
SBC AI Longevity Innovation Inc. combines the extensive data and clinical expertise of SBC Medical Group with AI technology to create new value in the longevity sector and drive an AI-native evolution of clinic operations and customer experience. Leveraging insights from actual clinic management and customer touchpoints, the company initially focuses on planning, developing, and deploying products within the group.
Following the "SBC AI Assistant," the company plans to commercialize products aimed at operational enhancement, including "AI Preceptor" (a staff training support system), AI-driven call center support solutions, and data utilization tools to advance longevity medicine. Looking ahead, the company aims to leverage its internal development and operational expertise to offer solutions to external medical institutions and healthcare providers.
Headquarters: 12F Shinjuku I-Land Tower, 6-5-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, Japan
President & Representative Director: Yuya Yoshida
Date of Establishment: July 1, 2026
Business Activities: Planning and development of products and services in AI and longevity domains; provision and operational support of AI solutions for medical institutions
Official Website: https://sbc-ai-longevity.com/
SBC Medical Group Holdings Incorporated
SBC Medical Group Holdings Incorporated is a Medical Services Organization (MSO) providing management support to medical institutions domestically and internationally across a wide range of specialties, including advanced cosmetic medicine, dermatology, orthopedics, fertility treatment, gynecology, dentistry, AGA treatment, and ophthalmology. Managing a diverse portfolio of clinic brands, the Company actively promotes medical tourism and global expansion across North America and Asia.
Listed on the NASDAQ Global Market in September 2024, the Company was subsequently added to the US Russell 3000® Index in June 2025. Guided by its corporate purpose to "contribute to enhancing the happiness of people worldwide through medical innovation," SBC Medical Group remains committed to delivering trusted medical services and expanding its network.
English Name: SBC Medical Group Holdings Incorporated
Stock Exchange: NASDAQ Global Market
Ticker Symbol: SBC
Headquarters: 200 Spectrum Center Drive Suite 300 Irvine, CA 92618 USA
CEO: Yoshiyuki Aikawa
Business Activities: Management support for healthcare providers (cosmetic medicine, dermatology,
orthopedics, fertility treatment, gynecology, dentistry, AGA treatment, ophthalmology, etc.)
Official Website: https://sbc-holdings.com
Official LinkedIn: https://www.linkedin.com/company/sbc-medical-group-holdings-inc
Shonan Beauty Clinic: https://www.s-b-c.net/
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements. These statements do not relate strictly to historical or current facts, but rather reflect management’s current views and assumptions regarding future events, strategies, sales and earnings growth, and business outlook. Forward-looking statements can generally be identified by words such as "may," "should," "expect," "anticipate," "intend," "estimate," "believe," "plan," "project," "potential," "target," "hope," or the negative of these terms and similar expressions.
These forward-looking statements speak only as of the date of this press release and are subject to risks, uncertainties, assumptions, and changes in circumstances that are difficult to predict or quantify. Therefore, undue reliance should not be placed on these statements. Forward-looking statements are based on current expectations and are not guarantees of future performance. Unless required by law, the Company undertakes no obligation to publicly update or revise any forward-looking statements to reflect changes in expectations or events, conditions, or circumstances on which any such statement is based. Actual results may differ materially from current expectations due to various factors, including global, regional, or local economic, business, competitive, market, and regulatory environmental changes, as well as the risk factors detailed in the Company's filings with the U.S. Securities and Exchange Commission (SEC), which are available at www.sec.gov.
Media Inquiries
SBC Medical Group Holdings Incorporated
Public Relations Department: Wakiyama
Email: pr@sbc.or.jp